Impact of a Clinical Pharmacist Intervention on Medicine Costs in Patients with Chronic Obstructive Pulmonary Disease in India

BACKGROUND: Chronic obstructive pulmonary disease (COPD) is a major cause of morbidity and mortality, especially in low- and middle-income countries (LMICs) such as India. Medicine costs are a key issue in LMICs, with typically high patient co-payments. In addition, pharmacists are underutilised in...

Descripción completa

Detalles Bibliográficos
Autores principales: Abdulsalim, Suhaj, Unnikrishnan, Mazhuvancherry Kesavan, Manu, Mohan K., Alsahali, Saud, Alrasheedy, Alian A., Martin, Antony P., Godman, Brian, Alfadl, Abubakr A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2019
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248138/
https://www.ncbi.nlm.nih.gov/pubmed/31368087
http://dx.doi.org/10.1007/s41669-019-0172-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7248138/
https://www.ncbi.nlm.nih.gov/pubmed/31368087
http://dx.doi.org/10.1007/s41669-019-0172-x

Ejemplares similares